These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 24947687

  • 1. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
    Mizuiri S, Nishizawa Y, Yamashita K, Ono K, Oda M, Usui K, Shigemoto K.
    Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K, Masajtis-Zagajewska A, Nowicki M.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ, Song BG, Kim MS, Cho S, Chun WJ, Oh JH, Kim SR.
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age].
    Bednarek-Skublewska A, Baranowicz-Gaszczyk I, Jóźwiak L, Dzik M, Majdan M, Ksiazek A.
    Pol Arch Med Wewn; 2005 May; 113(5):417-23. PubMed ID: 16479823
    [Abstract] [Full Text] [Related]

  • 9. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [Abstract] [Full Text] [Related]

  • 10. Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.
    Ashikaga E, Honda H, Suzuki H, Hosaka N, Hirai Y, Sanada D, Nakamura M, Nagai H, Matsumoto K, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):315-22. PubMed ID: 20609185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients.
    Chang YM, Tsai SC, Shiao CC, Liou HH, Yang CL, Tung NY, Hsu KS, Chen IL, Liu MC, Kao JL, Jhen RN, Huang YT.
    Clin Exp Nephrol; 2017 Oct; 21(5):908-916. PubMed ID: 27928636
    [Abstract] [Full Text] [Related]

  • 13. High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients.
    Hsu CW, Lin JL, Lin-Tan DT, Yen TH, Chen KH, Huang WH, Ho TC, Huang YL.
    Nephrology (Carlton); 2010 Apr; 15(3):313-20. PubMed ID: 20470300
    [Abstract] [Full Text] [Related]

  • 14. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
    Yamada S, Tsuruya K, Taniguchi M, Yoshida H, Tokumoto M, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Kitazono T.
    Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DETECTION OF MALNUTRITION IN PATIENTS UNDERGOING MAINTENANCE HAEMODIALYSIS: A QUANTITATIVE DATA ANALYSIS ON 12 PARAMETERS.
    Nafzger S, Fleury LA, Uehlinger DE, Plüss P, Scura N, Kurmann S.
    J Ren Care; 2015 Sep; 41(3):168-76. PubMed ID: 25899894
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
    Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Masutani K, Ooboshi H, Kitazono T.
    Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G, Charra B, Chazot C.
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.